CIK 0001833214 · Non-accelerated filer<br>Smaller reporting company<br>Emerging growth company
SAB Biotherapeutics, Inc.
Sign in to watch- Ticker
- SABS
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 853899721
- Phone
- 305-845-2813
- Business address
- 777 W 41ST ST, SUITE 401, MIAMI BEACH, FL, 33140
- Former names
- Big Cypress Acquisition Corp.
- NT 10-K Other NT 10-K
- 8-K Event Results of operations · Restatement
- 8-K Event New debt or obligation · Unregistered share sale
- 4 Insider Changes in Ownership
- 4 Insider Changes in Ownership
- 4 Insider Changes in Ownership
- 4 Insider Changes in Ownership
- 4 Insider Changes in Ownership
- 424B3 Offering Prospectus
- 4 Insider Changes in Ownership
- 4 Insider Changes in Ownership
- EFFECT Other Notice of Effectiveness
- 5 Insider Annual Insider Trading Report
- EFFECT Other Notice of Effectiveness
- CORRESP Other Correspondence Between Filers and SEC Staff
- UPLOAD Other SEC-generated Letter
- 8-K Event Regulation FD disclosure
- S-3 Offering Registration Statement
- POS AM Other Post-effective Amendment for Registration Statement
- 8-K Event Delisting notice
Page 12 of 22 · 433 filings